“…Decorin is a well-studied small leucine-rich proteoglycan (SLRP) with a complex genomic structure and complex promoter region regulated by various growth factors 158 , 159 , 160 , 161 Decorin has been implicated for a long time in the regulation of collagen fibrillogenesis, 162 , 163 , 164 , 165 , 166 cartilage and tendon homeostasis, 165 , 166 , 167 , 168 regulation of TGFβ activity, wound healing and fibrosis, 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 angiogenesis, 154 , 171 , 178 , 179 , 180 Lyme disease, 181 and ocular pathophysiology. 166 , 175 , 182 , 183 , 184 Soluble decorin inhibits cancer growth primarily by acting as a pan-RTK inhibitor 185 , 186 ; it binds to EGFR and downregulates its biological activity 187 , 188 , 189 , 190 while elevating cytosolic Ca 2+ in A431 carcinoma cells. 191 Decorin suppresses the growth of various tumors with different histopathological backgrounds, 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , …”